Graft Versus Host Disease Clinical Trials

336 clinical trials for Graft Versus Host Disease across international registries, including 38 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Evaluation of Patients With Immune Function Abnormalities — RECRUITING
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives — RECRUITING
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD — RECRUITING · PHASE1
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation — RECRUITING
Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT — RECRUITING · PHASE3
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant — RECRUITING · PHASE1
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning — RECRUITING · PHASE2
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant — RECRUITING · PHASE2
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia — RECRUITING · PHASE1
A Study of Ruxolitinib in Patients With Graft-Versus Host Disease — RECRUITING
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) — RECRUITING · PHASE1
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant — RECRUITING · PHASE2
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203) — RECRUITING · PHASE3
Cord Blood Transplantation in Children and Young Adults With Blood Cancer — RECRUITING · PHASE2
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors — RECRUITING · PHASE2
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation — RECRUITING · PHASE1
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma — RECRUITING · PHASE2
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant — RECRUITING · NA
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention — RECRUITING · PHASE2
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation — RECRUITING · PHASE3
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease — RECRUITING · NA
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis — RECRUITING · PHASE1
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation — RECRUITING · PHASE2
Relationship Between "FODMAPs" and "GVHD" — RECRUITING
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation — RECRUITING · PHASE2
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease — RECRUITING · PHASE3
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation — RECRUITING · PHASE2
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation. — RECRUITING · PHASE1
Quality of life in patients undergoing treatment for chronic graft-versus-host disease depending on extracorporeal photopheresis — RECRUITING
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients — RECRUITING
Dapagliflozin in Allo-HCT for aGVHD — RECRUITING · PHASE2
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography — RECRUITING
The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT — RECRUITING
Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD — RECRUITING
Safety and Efficacy of Fecal Microbiota Transplantation — RECRUITING · NA
Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT — RECRUITING · NA
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies — RECRUITING · PHASE2
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea — COMPLETED
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls — COMPLETED
Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone — COMPLETED · PHASE3
CINC424A2X01B Rollover Protocol — ACTIVE_NOT_RECRUITING · PHASE4
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease — COMPLETED · PHASE1
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT. — TERMINATED · PHASE1
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders — ACTIVE_NOT_RECRUITING · PHASE2
Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy Volunteers — NOT_YET_RECRUITING · PHASE1
Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation — COMPLETED · PHASE1
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE1
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus — TERMINATED · PHASE1
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease — COMPLETED · PHASE1

Refine this search